Last reviewed · How we verify
NCT03026634: HTx-HDZ-SDB-1
Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation
trial testing Sleep-disordered breathing in Sleep Disordered Breathing Central in 500 participants. Completed in 31 December 2020.
9 October 2020
Quick facts
| Lead sponsor | Heart and Diabetes Center North-Rhine Westfalia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 January 2017 |
| Primary completion | 9 October 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Sleep-disordered breathing
Conditions studied
- Sleep Disordered Breathing Central — all drugs for Sleep Disordered Breathing Central →
- Heart Failure — all drugs for Heart Failure →
- Heart Transplantation — all drugs for Heart Transplantation →
Sponsor
Heart and Diabetes Center North-Rhine Westfalia
Who can join
Adults 18 to 70, any sex, with Sleep Disordered Breathing Central or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep-disordered breathing is believed to appear at a high prevalence in end-stage heart failure patients and the presence of sleep-disordered breathing has been associated with increased mortality. This study is designed to investigate prevalence and dynamics of sleep-disordered breathing in end-stage heart failure patients pre and post heart transplantation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nocturnal Hypoxemic Burden Predicts Mortality in Patients Awaiting Heart Transplantation.
Potratz M, Manukyan T, Schramm R, Costard-Jäckle A, et al · · 2026 · PMID 41306066 · DOI 10.1111/jsr.70256
Verify or expand the search:
- PubMed search for NCT03026634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Heart and Diabetes Center North-Rhine Westfalia trials
Trials by the same sponsor.
- NCT06556485 — Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure · NA · recruiting
- NCT06951126 — CT Prediction for Transcatheter Tricuspid Interventions · recruiting
- NCT05873920 — Atrial Fibrillation and Diabetes Mellitus · unknown
- NCT05569317 — Patient-related Effects of Primary Nursing · NA · completed
- NCT04882488 — Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03026634 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heart and Diabetes Center North-Rhine Westfalia
- Last refreshed: 6 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03026634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing